Epicardial Echocardiography of Coronary Anastomoses Using the Echoclip Device

Sponsor
Aalborg University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02919124
Collaborator
Aalborg University (Other), Medistim ASA (Industry)
56
1
1
40
1.4

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate whether use of the echoclip device (an ultrasound transducer positioning device which can stabilize the involved part of the myocardium on the beating heart) facilitates imaging of coronary bypass anastomoses during coronary bypass surgery. A total of 100 low risk patients undergoing elective on-pump coronary bypass surgery will be included in the study in order to evaluate if the surgeons can visualize the coronary anastomoses before closure of the sternum. Ultrasonograpic pictures will be analyzed directly peroperatively and electronically post-operatively in order to evaluate if selected areas of the anastomoses can be visualized. Use of the echoclip devise will be considered a success if at least 80% of the anastomoses can be visualized.

Condition or Disease Intervention/Treatment Phase
  • Device: Echoclip
N/A

Detailed Description

The technical quality of coronary artery bypass anastomoses during coronary artery bypass grafting is often evaluated by measuring flow rate in grafts using transit time flowmetry. Unfortunately, flow rate and flow waveform are poor indicators of the anatomy of anastomoses. A better way to evaluate the anatomy of an anastomosis is 3-dimensional imaging. Three problems must be overcome in performing epicardial echocardiography on the beating heart:

  1. The transducer must be kept in a steady position relative to the anastomosis for 5 to 10 cardiac cycles to minimize frame-rate variability.

  2. Ultrasound gel must be kept in contact with the transducer and the region studied.

  3. The transducer must not cause any deformation of the vessels.

The investigators designed an ultrasound transducer positioning device, the Echoclip device (Aalborg Hospital, Aalborg, Denmark), which can stabilize the involved part of the myocardium on the beating heart, keep the gel at place, and position the ultrasound transducer correctly for imaging. The present study is a feasibility study with the aim to evaluate if the echoclip device facilitates imaging of coronary bypass anastomoses during coronary artery bypass surgery in humans to the same degree as was shown in animal studies. Ultrasonography will be used for visualizing all coronary anastomoses during 100 elective low-risk (logistic II EuroSCORE <6) on-pump coronary artery bypass procedures. It will be registered if the heel, the central portion and the toe of the anastomosis can be visualized in end-to-side and side-to-side anastomoses.Use of the echoclip devise will be considered a success if at least 80% of all parts of the anastomoses can be visualized either directly or by electronic reading using a special developed algorithm that may identify the inner border of the anastomoses.

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
During Coronary Artery Bypass Surgery. A Feasibility Study.
Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Echoclip device

Ultrasonography using the echoclip device

Device: Echoclip
An ultrasound transducer positioning device, the Echoclip device (Aalborg Hospital, Aalborg,Denmark), which can stabilize the involved part of the myocardium on the beating heart, keep the gel at place, and position the ultrasound transducer correctly for imaging will be used for visualising the coronary bypass anastomoses during surgery

Outcome Measures

Primary Outcome Measures

  1. Quality of periferal coronary artery bypass anastomotic structures [Peroperative]

    Ultrasonographic images of periferal coronary artery bypass anastomoses will be studied in order to evaluate if the area of anastomotic structures from various locations of the anastomoses (heel, central portion and the to toe) can be visualized directly on the screen using the echoclip device.

Secondary Outcome Measures

  1. Automatic quality control of periferal coronary artery bypass anastomotic structures [Peroperative]

    To quantify the anastomotic quality from epicardial utrasound images obtained peroperative, the area of anastomotic structures from various locations of the anastomoses (heel, central portion and the to toe) will be meassured using an automatic anastomosis segmentation algorithm to extract the area of the anastomotic structures. The ultrasound images obtained peroperative will be analyzed in the Laboratory when 50 patients and 100 patients have been included in the study, respectively.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Elective on-pump coronary artery bypass surgery

  • Surgery planned to be performed by specialist in cardiac surgery.

  • Logistic euroSCORE II <6%.

  • Must be able to read and understand the Danish

  • Written informed acceptance to participate

Exclusion Criteria:
  • Planned off-pump surgery.

  • Peroperativ conversion to off-pump surgery.

  • Logistic EuroSCORE II ≥ 6.

  • The patient do not understand written or spoken Danish.

  • Surgery within 24 hours after admittance to hospital

  • Patients in whom the surgeon wants to end the surgery in a hurry due to e.g. hemodynamic problems or peroperative complications.

  • The surgeon is not a specialist in cardiac surgery, e.g. surgeon in training.

  • Pregnant or brest feeding patient.

  • No written acceptance to participate.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aalborg University Hospital Aalborg Denmark 9100

Sponsors and Collaborators

  • Aalborg University Hospital
  • Aalborg University
  • Medistim ASA

Investigators

  • Principal Investigator: Jan J Andreasen, MD, PhD, Aalborg University Hospital and Aalborg University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jan Jesper Andreasen, Professor, MD, PhD, Professor, consultant, Aalborg University Hospital
ClinicalTrials.gov Identifier:
NCT02919124
Other Study ID Numbers:
  • 0089Y
First Posted:
Sep 29, 2016
Last Update Posted:
Jan 3, 2020
Last Verified:
Jan 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Jan Jesper Andreasen, Professor, MD, PhD, Professor, consultant, Aalborg University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 3, 2020